Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1997;17:2759-2764

This Article
Right arrow Full Text
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Helbecque, N.
Right arrow Articles by Amouyel, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Helbecque, N.
Right arrow Articles by Amouyel, P.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 1997;17:2759-2764.)
© 1997 American Heart Association, Inc.


Articles

The Role of a Triplet Repeat Sequence of the Very Low Density Lipoprotein Receptor Gene in Plasma Lipid and Lipoprotein Level Variability in Humans

Nicole Helbecque; Jean Dallongeville; Valérie Codron; Dominique Arveiler; Jean-Bernard Ruidavets; Alun Evans; François Cambien; Jean-Charles Fruchart; ; Philippe Amouyel

From the Service d'Epidémiologie et de Santé Publique—INSERM CJF 95-05, Institut Pasteur de Lille (N.H., V.C., P.A.); INSERM U 325, Institut Pasteur de Lille (J.D., J.-C.F.), Lille France; Laboratoire d'Epidémiologie et de Santé Publique, Strasbourg France (D.A.); Département d'Epidémiologie, Faculté de Médecine, Toulouse (J.-B.R.) France; Department of Epidemiology and Public Health, The Queen's University of Belfast, Belfast, Northern Ireland (A.E.); INSERM SC7, Paris, France (F.C.)

Correspondence to Pr Philippe Amouyel, Service d'Epidémiologie et de Santé Publique et INSERM, CJF 95-05, Institut Pasteur de Lille, 1 rue du Professeur Calmette, 59019 Lille Cedex, France.

Abstract The biological role of the very low density lipoprotein receptor (VLDL-R) in humans is not yet elucidated. This cellular receptor binds apolipoprotein E (apoE)-containing lipoparticles and is mainly expressed in peripheral tissues. The VLDL-R gene contains a polymorphic triplet (CGG) repeat located 19 bp upstream of the initiation codon. We explored the allelic distribution of this repeat in 1384 subjects of European Caucasian origin, 609 of them surviving a myocardial infarction. Six alleles corresponding to 5, 6, 7, 8, 9, and 11 repeats were detected in this population. The alleles 5, 8, and 9 were the most frequent, with frequencies of 0.413, 0.275, and 0.292, respectively. No association was found between the VLDL-R polymorphism and myocardial infarction. In controls without lipid lowering treatment, a statistically significant interaction between VLDL-R genotype and apoE phenotype was found for plasma triglycerides (P<.04), suggesting a gene-gene interaction. There was also a main effect of the VLDL-R polymorphism on LpE:B and LpA-I. The VLDL-R 9 allele was associated with lower levels of plasma LpE:B (P<.05) and higher concentrations of plasma LpA-I (P<.01) than the other alleles. These results suggest that VLDL-R has a modest influence on circulating lipoproteins in humans.


Key Words: VLDL receptor • triglyceride-rich lipoproteins • polymorphism • lipoprotein metabolism